Did Boston Scientific Corporation Lose $74 Million Mesh Trial Over An Email?

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medtech titan Boston Scientific’s (NYSE:BSX) logged a major loss after winning a few rounds in the ongoing lawsuits over its vaginal sling implants, and the deciding factor may have been the revelation of an internal company email.

The Marlborough, Mass.-based medical device company won the first 2 lawsuits to go to trial in a Massachusetts state court, but a Dallas jury ruled earlier this month that Boston Scientific’s Obtryx pelvic mesh device caused Martha Salazar’s injuries, awarding her $73.5 million in damages.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC